Your RSA-2048 keys break in 2030. Find every one of them before attackers do.
🐘 Packagist

CVE-2017-15051

MEDIUM

TeamPass stored cross-site scripting (XSS) vulnerability

Also known asGHSA-r68m-4v39-cf43
Published
Nov 27, 2017
Updated
Apr 10, 2026
Affected
1 pkg
Patched
1 / 1
Exploits
1 known

EPSS Exploitation Probability

via FIRST.org ↗
1.0%probability of exploitation in next 30 days
Lower Risk57th percentile+0.80%
0.00%0.48%0.97%1.46%0.1%1.0%Dec 25Apr 26Jun 26

EPSS (Exploit Prediction Scoring System) is a daily probability model maintained by FIRST.org. It estimates the likelihood a CVE will be exploited in production environments within the next 30 days, derived from real-world threat intelligence signals.

Blast Radius

1 pkg affected
🐘nilsteampassnet/teampass

Real-time download stats are indexed for npm and PyPI packages. This vulnerability affects Packagist packages — download data is not available via public APIs for these ecosystems.

Description

Multiple stored cross-site scripting (XSS) vulnerabilities in TeamPass before 2.1.27.9 allow authenticated remote attackers to inject arbitrary web script or HTML via the (1) URL value of an item or (2) user log history. To exploit the vulnerability, the attacker must be first authenticated to the application. For the first one, the attacker has to simply inject XSS code within the URL field of a shared item. For the second one however, the attacker must prepare a payload within its profile, and then ask an administrator to modify its profile. From there, whenever the administrator accesses the log, it can be XSS'ed.

Affected Packages

1 total 1 fixed
EcosystemPackageVulnerable rangeFix
🐘Packagistnilsteampassnet/teampassall versions2.1.27.9
Exploits & PoCs
1

Research use only. For defensive security, authorized penetration testing, and academic research only. Never execute exploit code against systems without explicit written authorization.

Detection & mitigation playbook

Open-source dependency
  1. Detect

    Scan your dependency tree (package-lock.json, pnpm-lock.yaml, requirements.txt, go.sum, etc.) for nilsteampassnet/teampass. O3's reachability analysis confirms whether the vulnerable code path is actually invoked in your application, so you act on real exposure instead of every transitive match.

  2. Fix

    Update nilsteampassnet/teampass to 2.1.27.9 or later, then make sure no transitive (indirect) dependency still pins the vulnerable range — O3 confirms CVE-2017-15051 is resolved across your whole dependency graph.

  3. Workarounds

    If you can't upgrade right away: gate or disable the affected feature, validate untrusted input at the boundary, and avoid passing attacker-controlled data into the vulnerable path. O3's runtime protection blocks exploitation in production as an interim safeguard until the upgrade lands.

  4. How O3 protects you

    O3 pinpoints whether CVE-2017-15051 is reachable in your code and exactly where to fix it, then blocks exploitation in production at runtime until the patched version is deployed.

Tailored to CVE-2017-15051. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.

Frequently Asked Questions

Multiple stored cross-site scripting (XSS) vulnerabilities in TeamPass before 2.1.27.9 allow authenticated remote attackers to inject arbitrary web script or HTML via the (1) URL value of an item or (2) user log history. To exploit the vulnerability, the attacker must be first authenticated to the application. For the first one, the attacker has to simply inject XSS code within the URL field of a shared item. For the second one however, the attacker must prepare a payload within its profile, and then ask an administrator to modify its profile. From there, whenever the administrator accesses th
O3 Security · Impact-Aware SCA

Is CVE-2017-15051 in your dependencies?

O3 detects CVE-2017-15051 across Packagist dependencies and uses function-level reachability to confirm whether the vulnerable code path is actually reachable — not just present. No false positives.